4.6 Article

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 20, Issue 30, Pages 3677-3692

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867311320999165

Keywords

Antioxidants; cancer biology; cancer progression; cancer therapy; carcinogenesis; reactive oxygen species

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [BA 3826/5-1]

Ask authors/readers for more resources

Reactive oxygen species (ROS) are a group of highly reactive chemicals under tight control of intracellular antioxidants. The balance in oxidation-antioxidation is essential for maintaining normal cell functions, and any imbalance could lead to a wide range of diseases including cancer. The intracellular level of ROS is generally elevated in cancer cells, revealing a critical role of ROS in the process of carcinogenesis and cancer progression. Conversely, there is also evidence showing that ROS can act as cancer suppressors. This may be due to the varying antioxidant capacities of different cancers. These findings indicate a complex redox state in cancer cells. In this review we summarize the main features of ROS and their functions with respect to cancer initiation, hallmarks of cancer, and signaling in cancer cells. ROS-elevating and ROS-depleting anticancer strategies and their mechanisms are thoroughly discussed. We argue that the rationale for therapy choice depends on a complete understanding of cancer cell redox state, namely, the redox signaling signature of cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available